Related Experiment Video
Updated: Jan 28, 2026

siRNA Electroporation to Modulate Autophagy in Herpes Simplex Virus Type 1-Infected Monocyte-Derived Dendritic Cells
Published on: October 28, 2019
Hydroxychloroquine antiparkinsonian potential: Nurr1 modulation versus autophagy inhibition
Shireen A Hedya1, Marwa M Safar2, Ashraf K Bahgat1
1Pharmacology & Toxicology Department, Faculty of Pharmacy, Cairo University, Egypt.
Abstract:
The nuclear orphan receptor (Nurr1) has recently received a perceivable solicitude as a target for the therapeutic intervention against PD. Meanwhile, the dysregulation of autophagy, along with other processes is believed to contribute massively to PD pathophysiology. Hydroxychloroquine, a hydroxy derivative of chloroquine, is an antimalarial agent which is also used as an anti-rheumatic drug. The neuroprotective potential of hydroxychloroquine and chloroquine remained controversial until recently a study showed that chloroquine exhibited an antiparkinsonian activity through Nurr1 modulation. The aim of this work is to identify whether the less toxic derivative, hydroxychloroquine, could show a similar pattern. In rat rotenone model, hydroxychloroquine effectively boosted Nurr-1 expression, exhibited an anti-inflammatory effect as verified by hindering certain pro-inflammatory cytokines and successfully reduced GSK-3β activity. Consequently, an increase in the striatal tyrosine hydroxylase content, as well as improved locomotion and muscle coordination was shown. However, this improvement was opposed by hydroxychloroquine induced autophagic inhibition as manifested by enhancing both LC3-II and P62 levels possibly through the prominent decline in sirtuin 1 level and elevated apoptotic biomarkers. In conclusion, hydroxychloroquine successfully ameliorated PD motor dysfunction in spite of the fact that both autophagy and apoptosis were deregulated through Nurr1 modulation.
Insights
Hydroxychloroquine improved Parkinson's disease (PD) motor symptoms by boosting Nurr1 expression and reducing inflammation. However, it also inhibited autophagy and increased apoptosis, suggesting complex therapeutic effects.
Area of Science:
- Neuroscience
- Pharmacology
- Cell Biology
Background:
- Parkinson's disease (PD) pathophysiology involves autophagy dysregulation.
- Nurr1 (nuclear orphan receptor) is a potential therapeutic target for PD.
- Hydroxychloroquine (HCQ) is an antimalarial and anti-rheumatic drug with controversial neuroprotective potential.
Purpose of the Study:
- To investigate if hydroxychloroquine (HCQ) exhibits antiparkinsonian activity via Nurr1 modulation.
- To assess HCQ's effects on neuroinflammation, autophagy, and apoptosis in a rat rotenone model of PD.
Main Methods:
- Utilized a rat rotenone model to induce Parkinson's-like pathology.
- Administered hydroxychloroquine (HCQ) and assessed its impact on Nurr1 expression, pro-inflammatory cytokines, GSK-3β activity, and tyrosine hydroxylase content.
- Evaluated autophagy markers (LC3-II, P62, sirtuin 1) and apoptotic biomarkers.
Main Results:
- HCQ boosted Nurr1 expression, reduced inflammation, and decreased GSK-3β activity, leading to improved motor function.
- HCQ increased striatal tyrosine hydroxylase content, enhancing locomotion and muscle coordination.
- HCQ induced autophagic inhibition and elevated apoptosis, potentially linked to reduced sirtuin 1 levels.
Conclusions:
- Hydroxychloroquine ameliorated motor dysfunction in a rat PD model through Nurr1 modulation.
- Despite positive motor effects, HCQ deregulated autophagy and apoptosis, indicating a complex therapeutic profile.
- Further research is needed to balance the benefits of Nurr1 modulation with the adverse effects on autophagy and apoptosis.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Feedback Inhibition
Enzyme Inhibition
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Inhibition of Cdk Activity
Standard Electrode Potentials

